Skip to main content
PHARMARESEARCH BIO Co., Ltd. logo

PHARMARESEARCH BIO Co., Ltd. — Investor Relations & Filings

Ticker · 217950 ISIN · KR7217950005 KO Manufacturing
Open in API
Filings indexed 162 across all filing types
Latest filing 2019-10-22 Investor Presentation
Country KR South Korea
Listing KO 217950

About PHARMARESEARCH BIO Co., Ltd.

http://www.pr-bio.co.kr/eng/

PHARMARESEARCH BIO Co., Ltd. is a biopharmaceutical company specializing in regenerative medicine. The company leverages marine biotechnology to research, develop, and produce innovative biological products aimed at enhancing human health. Its core activities center on the development of raw materials for cell and tissue regeneration, such as Polydeoxyribonucleotide (PDRN) and Polynucleotide (PN) derived from salmon DNA. The company's research and development pipeline also includes other biological products, such as toxin-based therapeutics, to address various medical and aesthetic needs.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최결과
Investor Presentation Classification · 95% confidence The document is a formal notification regarding the results of an Investor Relations (IR) meeting held by PharmaResearchBio. It lists the date, location, attendees, and agenda items of the meeting. Since it is a short regulatory announcement confirming that an IR event took place and where the materials can be found, rather than the presentation slides themselves, it falls under the category of a regulatory filing or announcement of an event.
2019-10-22 Korean
기타주요경영사항(자율공시)(라이선스계약 체결)
M&A Activity Classification · 95% confidence The document is a regulatory disclosure (자율공시) regarding a license agreement (라이선스계약 체결) between Pharma Research Bio and LG Chem. It details the terms of the contract, including milestones and financial conditions. Since it is a specific corporate announcement regarding a business transaction/partnership that does not fit into the other specific categories like M&A or financial reports, it is classified as a general regulatory filing.
2019-10-15 Korean
기업설명회(IR)개최
Investor Presentation Classification · 98% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, target audience, and purpose of the meeting. Since it is an announcement of an event rather than the presentation materials themselves or a financial report, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2019-10-11 Korean
전환가액의조정(제3회차)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory announcement regarding the adjustment of the conversion price for convertible bonds (3rd series) issued by PharmaResearchBio. It details the change in conversion price, the number of convertible shares, the reason for the adjustment (market price decline), and the calculation methodology. This falls under capital structure changes related to convertible debt instruments, which is classified as a Capital/Financing Update.
2019-07-22 Korean
[기재정정]사업보고서 (2018.12)
Annual Report Classification · 95% confidence The document is a 'Correction Report' (정정신고) for a previously filed 'Business Report' (사업보고서), which is the Korean equivalent of an Annual Report (10-K). It details specific corrections made to sections regarding research and development, major shareholder changes, and executive compensation. Since it is a formal amendment to an existing annual filing, it falls under the category of regulatory filings or amendments to annual reports. FY 2018
2019-07-04 Korean
전환가액의조정(제2회차)
Capital/Financing Update Classification · 95% confidence The document is an official announcement regarding the adjustment of the conversion price for convertible bonds (제2회차 전환사채). This type of filing relates to changes in the company's capital structure and financing terms. According to the provided definitions, 'Capital/Financing Update' (CAP) is the most appropriate category for updates on financing activities and capital structure changes.
2019-06-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.